Epidemiologic and Clinical Outcomes of Pediatric Renal Tumors in Korea: A Retrospective Analysis of The Korean Pediatric Hematology and Oncology Group (KPHOG) Data

PurposeRenal tumors account for approximately 7% of all childhood cancers. These include Wilms tumor (WT), clear cell sarcoma of the kidney (CCSK), malignant rhabdoid tumor of the kidney (MRTK), renal cell carcinoma (RCC), congenital mesoblastic nephroma (CMN) and other rare tumors. We investigated...

Full description

Saved in:
Bibliographic Details
Published inCancer research and treatment Vol. 55; no. 1; pp. 279 - 290
Main Authors Koh, Kyung-Nam, Han, Jung Woo, Choi, Hyoung Soo, Kang, Hyoung Jin, Lee, Ji Won, Yoo, Keon Hee, Sung, Ki Woong, Koo, Hong Hoe, Hong, Kyung Taek, Choi, Jung Yoon, Kang, Sung Han, Kim, Hyery, Im, Ho Joon, Hahn, Seung Min, Lyu, Chuhl Joo, Baek, Hee-Jo, Kook, Hoon, Park, Kyung Mi, Yang, Eu Jeen, Lim, Young Tak, Kim, Seongkoo, Lee, Jae Wook, Chung, Nack-Gyun, Cho, Bin, Park, Meerim, Park, Hyeon Jin, Park, Byung-Kiu, Lee, Jun Ah, Park, Jun Eun, Kim, Soon Ki, Kim, Ji Yoon, Kim, Hyo Sun, Ma, Youngeun, Park, Kyung Duk, Park, Sang Kyu, Park, Eun Sil, Shim, Ye Jee, Yoo, Eun Sun, Ryu, Kyung Ha, Yoo, Jae Won, Lim, Yeon Jung, Yoon, Hoi Soo, Lee, Mee Jeong, Lee, Jae Min, Jeon, In-Sang, Jung, Hye Lim, Chueh, Hee Won, Won, Seunghyun
Format Journal Article
LanguageEnglish
Published Korea (South) Korean Cancer Association 01.01.2023
대한암학회
Subjects
Carcinoma, Renal Cell - epidemiology
Child
Humans
Kidney Neoplasms - drug therapy
Kidney Neoplasms - therapy
Male
Neoplasm Recurrence, Local
Nephroma, Mesoblastic - congenital
Nephroma, Mesoblastic - metabolism
Nephroma, Mesoblastic - pathology
Original
Republic of Korea - epidemiology
Retrospective Studies
Rhabdoid Tumor - pathology
Sarcoma
Wilms Tumor
의학일반
Republic of Korea
Renal tumors
Child
Epidemiology
Online AccessGet full text
ISSN1598-2998
2005-9256
2005-9256
DOI10.4143/crt.2022.073

Cover

Abstract PurposeRenal tumors account for approximately 7% of all childhood cancers. These include Wilms tumor (WT), clear cell sarcoma of the kidney (CCSK), malignant rhabdoid tumor of the kidney (MRTK), renal cell carcinoma (RCC), congenital mesoblastic nephroma (CMN) and other rare tumors. We investigated the epidemiology of pediatric renal tumors in Korea.Materials and MethodsFrom January 2001 to December 2015, data of pediatric patients (0–18 years) newly-diagnosed with renal tumors at 26 hospitals were retrospectively analyzed.ResultsAmong 439 patients (male, 240), the most common tumor was WT (n=342, 77.9%), followed by RCC (n=36, 8.2%), CCSK (n=24, 5.5%), MRTK (n=16, 3.6%), CMN (n=12, 2.7%), and others (n=9, 2.1%). Median age at diagnosis was 27.1 months (range 0-225.5) and median follow-up duration was 88.5 months (range 0-211.6). Overall, 32 patients died, of whom 17, 11, 1, and 3 died of relapse, progressive disease, second malignant neoplasm, and treatment-related mortality. Five-year overall survival and event free survival were 97.2% and 84.8% in WT, 90.6% and 82.1% in RCC, 81.1% and 63.6% in CCSK, 60.3% and 56.2% in MRTK, and 100% and 91.7% in CMN, respectively (p < 0.001).ConclusionThe pediatric renal tumor types in Korea are similar to those previously reported in other countries. WT accounted for a large proportion and survival was excellent. Non-Wilms renal tumors included a variety of tumors and showed inferior outcome, especially MRTK. Further efforts are necessary to optimize the treatment and analyze the genetic characteristics of pediatric renal tumors in Korea.
AbstractList Renal tumors account for approximately 7% of all childhood cancers. These include Wilms tumor (WT), clear cell sarcoma of the kidney (CCSK), malignant rhabdoid tumor of the kidney (MRTK), renal cell carcinoma (RCC), congenital mesoblastic nephroma (CMN) and other rare tumors. We investigated the epidemiology of pediatric renal tumors in Korea.PURPOSERenal tumors account for approximately 7% of all childhood cancers. These include Wilms tumor (WT), clear cell sarcoma of the kidney (CCSK), malignant rhabdoid tumor of the kidney (MRTK), renal cell carcinoma (RCC), congenital mesoblastic nephroma (CMN) and other rare tumors. We investigated the epidemiology of pediatric renal tumors in Korea.From January 2001 to December 2015, data of pediatric patients (0-18 years) newly-diagnosed with renal tumors at 26 hospitals were retrospectively analyzed.MATERIALS AND METHODSFrom January 2001 to December 2015, data of pediatric patients (0-18 years) newly-diagnosed with renal tumors at 26 hospitals were retrospectively analyzed.Among 439 patients (male, 240), the most common tumor was WT (n=342, 77.9%), followed by RCC (n=36, 8.2%), CCSK (n=24, 5.5%), MRTK (n=16, 3.6%), CMN (n=12, 2.7%), and others (n=9, 2.1%). Median age at diagnosis was 27.1 months (range 0-225.5) and median follow-up duration was 88.5 months (range 0-211.6). Overall, 32 patients died, of whom 17, 11, 1, and 3 died of relapse, progressive disease, second malignant neoplasm, and treatment-related mortality. Five-year overall survival and event free survival were 97.2% and 84.8% in WT, 90.6% and 82.1% in RCC, 81.1% and 63.6% in CCSK, 60.3% and 56.2% in MRTK, and 100% and 91.7% in CMN, respectively (p < 0.001).RESULTSAmong 439 patients (male, 240), the most common tumor was WT (n=342, 77.9%), followed by RCC (n=36, 8.2%), CCSK (n=24, 5.5%), MRTK (n=16, 3.6%), CMN (n=12, 2.7%), and others (n=9, 2.1%). Median age at diagnosis was 27.1 months (range 0-225.5) and median follow-up duration was 88.5 months (range 0-211.6). Overall, 32 patients died, of whom 17, 11, 1, and 3 died of relapse, progressive disease, second malignant neoplasm, and treatment-related mortality. Five-year overall survival and event free survival were 97.2% and 84.8% in WT, 90.6% and 82.1% in RCC, 81.1% and 63.6% in CCSK, 60.3% and 56.2% in MRTK, and 100% and 91.7% in CMN, respectively (p < 0.001).The pediatric renal tumor types in Korea are similar to those previously reported in other countries. WT accounted for a large proportion and survival was excellent. Non-Wilms renal tumors included a variety of tumors and showed inferior outcome, especially MRTK. Further efforts are necessary to optimize the treatment and analyze the genetic characteristics of pediatric renal tumors in Korea.CONCLUSIONThe pediatric renal tumor types in Korea are similar to those previously reported in other countries. WT accounted for a large proportion and survival was excellent. Non-Wilms renal tumors included a variety of tumors and showed inferior outcome, especially MRTK. Further efforts are necessary to optimize the treatment and analyze the genetic characteristics of pediatric renal tumors in Korea.
PurposeRenal tumors account for approximately 7% of all childhood cancers. These include Wilms tumor (WT), clear cell sarcoma of the kidney (CCSK), malignant rhabdoid tumor of the kidney (MRTK), renal cell carcinoma (RCC), congenital mesoblastic nephroma (CMN) and other rare tumors. We investigated the epidemiology of pediatric renal tumors in Korea.Materials and MethodsFrom January 2001 to December 2015, data of pediatric patients (0–18 years) newly-diagnosed with renal tumors at 26 hospitals were retrospectively analyzed.ResultsAmong 439 patients (male, 240), the most common tumor was WT (n=342, 77.9%), followed by RCC (n=36, 8.2%), CCSK (n=24, 5.5%), MRTK (n=16, 3.6%), CMN (n=12, 2.7%), and others (n=9, 2.1%). Median age at diagnosis was 27.1 months (range 0-225.5) and median follow-up duration was 88.5 months (range 0-211.6). Overall, 32 patients died, of whom 17, 11, 1, and 3 died of relapse, progressive disease, second malignant neoplasm, and treatment-related mortality. Five-year overall survival and event free survival were 97.2% and 84.8% in WT, 90.6% and 82.1% in RCC, 81.1% and 63.6% in CCSK, 60.3% and 56.2% in MRTK, and 100% and 91.7% in CMN, respectively (p < 0.001).ConclusionThe pediatric renal tumor types in Korea are similar to those previously reported in other countries. WT accounted for a large proportion and survival was excellent. Non-Wilms renal tumors included a variety of tumors and showed inferior outcome, especially MRTK. Further efforts are necessary to optimize the treatment and analyze the genetic characteristics of pediatric renal tumors in Korea. KCI Citation Count: 0
PurposeRenal tumors account for approximately 7% of all childhood cancers. These include Wilms tumor (WT), clear cell sarcoma of the kidney (CCSK), malignant rhabdoid tumor of the kidney (MRTK), renal cell carcinoma (RCC), congenital mesoblastic nephroma (CMN) and other rare tumors. We investigated the epidemiology of pediatric renal tumors in Korea.Materials and MethodsFrom January 2001 to December 2015, data of pediatric patients (0–18 years) newly-diagnosed with renal tumors at 26 hospitals were retrospectively analyzed.ResultsAmong 439 patients (male, 240), the most common tumor was WT (n=342, 77.9%), followed by RCC (n=36, 8.2%), CCSK (n=24, 5.5%), MRTK (n=16, 3.6%), CMN (n=12, 2.7%), and others (n=9, 2.1%). Median age at diagnosis was 27.1 months (range 0-225.5) and median follow-up duration was 88.5 months (range 0-211.6). Overall, 32 patients died, of whom 17, 11, 1, and 3 died of relapse, progressive disease, second malignant neoplasm, and treatment-related mortality. Five-year overall survival and event free survival were 97.2% and 84.8% in WT, 90.6% and 82.1% in RCC, 81.1% and 63.6% in CCSK, 60.3% and 56.2% in MRTK, and 100% and 91.7% in CMN, respectively (p < 0.001).ConclusionThe pediatric renal tumor types in Korea are similar to those previously reported in other countries. WT accounted for a large proportion and survival was excellent. Non-Wilms renal tumors included a variety of tumors and showed inferior outcome, especially MRTK. Further efforts are necessary to optimize the treatment and analyze the genetic characteristics of pediatric renal tumors in Korea.
Renal tumors account for approximately 7% of all childhood cancers. These include Wilms tumor (WT), clear cell sarcoma of the kidney (CCSK), malignant rhabdoid tumor of the kidney (MRTK), renal cell carcinoma (RCC), congenital mesoblastic nephroma (CMN) and other rare tumors. We investigated the epidemiology of pediatric renal tumors in Korea. From January 2001 to December 2015, data of pediatric patients (0-18 years) newly-diagnosed with renal tumors at 26 hospitals were retrospectively analyzed. Among 439 patients (male, 240), the most common tumor was WT (n=342, 77.9%), followed by RCC (n=36, 8.2%), CCSK (n=24, 5.5%), MRTK (n=16, 3.6%), CMN (n=12, 2.7%), and others (n=9, 2.1%). Median age at diagnosis was 27.1 months (range 0-225.5) and median follow-up duration was 88.5 months (range 0-211.6). Overall, 32 patients died, of whom 17, 11, 1, and 3 died of relapse, progressive disease, second malignant neoplasm, and treatment-related mortality. Five-year overall survival and event free survival were 97.2% and 84.8% in WT, 90.6% and 82.1% in RCC, 81.1% and 63.6% in CCSK, 60.3% and 56.2% in MRTK, and 100% and 91.7% in CMN, respectively (p < 0.001). The pediatric renal tumor types in Korea are similar to those previously reported in other countries. WT accounted for a large proportion and survival was excellent. Non-Wilms renal tumors included a variety of tumors and showed inferior outcome, especially MRTK. Further efforts are necessary to optimize the treatment and analyze the genetic characteristics of pediatric renal tumors in Korea.
Author Kim, Soon Ki
Lee, Jun Ah
Park, Kyung Duk
Kim, Hyery
Kim, Hyo Sun
Lyu, Chuhl Joo
Kang, Hyoung Jin
Im, Ho Joon
Kook, Hoon
Choi, Hyoung Soo
Jeon, In-Sang
Lee, Jae Wook
Park, Meerim
Kim, Ji Yoon
Chueh, Hee Won
Hahn, Seung Min
Choi, Jung Yoon
Lee, Mee Jeong
Lee, Ji Won
Yoo, Eun Sun
Kang, Sung Han
Koo, Hong Hoe
Park, Jun Eun
Yoo, Jae Won
Jung, Hye Lim
Hong, Kyung Taek
Ma, Youngeun
Ryu, Kyung Ha
Lee, Jae Min
Sung, Ki Woong
Yang, Eu Jeen
Koh, Kyung-Nam
Park, Sang Kyu
Won, Seunghyun
Yoo, Keon Hee
Park, Byung-Kiu
Park, Eun Sil
Lim, Yeon Jung
Kim, Seongkoo
Cho, Bin
Han, Jung Woo
Park, Kyung Mi
Chung, Nack-Gyun
Yoon, Hoi Soo
Baek, Hee-Jo
Lim, Young Tak
Park, Hyeon Jin
Shim, Ye Jee
AuthorAffiliation 9 Department of Pediatrics, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea
11 Department of Pediatrics, Korea Cancer Center Hospital, Seoul, Korea
20 Department of Pediatrics, Ewha Womans University Seoul Hospital, Ewha Womans University College of Medicine, Seoul, Korea
8 Department of Pediatrics, Pusan National University School of Medicine, Yangsan, Korea
5 Seoul National University Cancer Institute, Seoul, Korea
17 Department of Pediatrics, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea
10 Center for Pediatric Cancer, Department of Pediatrics, National Cancer Center, Goyang, Korea
15 Department of Pediatrics, Inje University Haeundae Paik Hospital, Busan, Korea
18 Department of Pediatrics, Gyeongsang National University School of Medicine, Jinju, Korea
23 Department of Pediatrics, Dankook University College of Medicine, Cheonan, Korea
1 Division of Pediatric Hematology/Oncology, Department of Pediatrics, Asan M
AuthorAffiliation_xml – name: 11 Department of Pediatrics, Korea Cancer Center Hospital, Seoul, Korea
– name: 20 Department of Pediatrics, Ewha Womans University Seoul Hospital, Ewha Womans University College of Medicine, Seoul, Korea
– name: 8 Department of Pediatrics, Pusan National University School of Medicine, Yangsan, Korea
– name: 22 Department of Pediatrics, Kyung Hee University College of Medicine, Seoul, Korea
– name: 19 Department of Pediatrics, Keimyung University Dongsan Hospital, Keimyung University School of Medicine, Daegu, Korea
– name: 10 Center for Pediatric Cancer, Department of Pediatrics, National Cancer Center, Goyang, Korea
– name: 13 Department of Pediatrics, Inha University Hospital, Inha University College of Medicine, Incheon, Korea
– name: 14 Department of Pediatrics, School of Medicine, Kyungpook National University, Kyungpook National University Hospital, Daegu, Korea
– name: 12 Department of Pediatrics, Korea University School of Medicine, Seoul, Korea
– name: 21 Department of Pediatrics, Chungnam National University College of Medicine, Daejeon, Korea
– name: 1 Division of Pediatric Hematology/Oncology, Department of Pediatrics, Asan Medical Center Children’s Hospital, University of Ulsan College of Medicine, Seoul, Korea
– name: 24 Department of Pediatrics, Yeungnam University College of Medicine, Daegu, Korea
– name: 15 Department of Pediatrics, Inje University Haeundae Paik Hospital, Busan, Korea
– name: 5 Seoul National University Cancer Institute, Seoul, Korea
– name: 17 Department of Pediatrics, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea
– name: 23 Department of Pediatrics, Dankook University College of Medicine, Cheonan, Korea
– name: 27 Department of Pediatrics, Dong-A University College of Medicine, Busan, Korea
– name: 6 Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
– name: 16 Department of Pediatrics and Research Institute of Clinical Medicine of Jeonbuk National University-Jeonbuk National University Hospital, Jeonbuk National University Medical School, Jeonju, Korea
– name: 7 Department of Pediatrics, Chonnam National University Hwasun Hospital, Chonnam National University Medical School, Gwangju, Korea
– name: 4 Department of Pediatrics, Seoul National University College of Medicine, Seoul, Korea
– name: 9 Department of Pediatrics, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea
– name: 3 Department of Pediatrics, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea
– name: 18 Department of Pediatrics, Gyeongsang National University School of Medicine, Jinju, Korea
– name: 26 Department of Pediatrics, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea
– name: 2 Division of Pediatric Hematology and Oncology, Department of Pediatrics, Yonsei University College of Medicine, Seoul, Korea
– name: 25 Department of Pediatrics, Gachon University Gil Medical Center, Incheon, Korea
– name: 28 Medical Research Collaborating Center, Seoul National University Bundang Hospital, Seongnam, Korea
Author_xml – sequence: 1
  givenname: Kyung-Nam
  surname: Koh
  fullname: Koh, Kyung-Nam
– sequence: 2
  givenname: Jung Woo
  surname: Han
  fullname: Han, Jung Woo
– sequence: 3
  givenname: Hyoung Soo
  surname: Choi
  fullname: Choi, Hyoung Soo
– sequence: 4
  givenname: Hyoung Jin
  surname: Kang
  fullname: Kang, Hyoung Jin
– sequence: 5
  givenname: Ji Won
  surname: Lee
  fullname: Lee, Ji Won
– sequence: 6
  givenname: Keon Hee
  surname: Yoo
  fullname: Yoo, Keon Hee
– sequence: 7
  givenname: Ki Woong
  surname: Sung
  fullname: Sung, Ki Woong
– sequence: 8
  givenname: Hong Hoe
  surname: Koo
  fullname: Koo, Hong Hoe
– sequence: 9
  givenname: Kyung Taek
  surname: Hong
  fullname: Hong, Kyung Taek
– sequence: 10
  givenname: Jung Yoon
  surname: Choi
  fullname: Choi, Jung Yoon
– sequence: 11
  givenname: Sung Han
  surname: Kang
  fullname: Kang, Sung Han
– sequence: 12
  givenname: Hyery
  surname: Kim
  fullname: Kim, Hyery
– sequence: 13
  givenname: Ho Joon
  surname: Im
  fullname: Im, Ho Joon
– sequence: 14
  givenname: Seung Min
  surname: Hahn
  fullname: Hahn, Seung Min
– sequence: 15
  givenname: Chuhl Joo
  surname: Lyu
  fullname: Lyu, Chuhl Joo
– sequence: 16
  givenname: Hee-Jo
  surname: Baek
  fullname: Baek, Hee-Jo
– sequence: 17
  givenname: Hoon
  surname: Kook
  fullname: Kook, Hoon
– sequence: 18
  givenname: Kyung Mi
  surname: Park
  fullname: Park, Kyung Mi
– sequence: 19
  givenname: Eu Jeen
  surname: Yang
  fullname: Yang, Eu Jeen
– sequence: 20
  givenname: Young Tak
  surname: Lim
  fullname: Lim, Young Tak
– sequence: 21
  givenname: Seongkoo
  surname: Kim
  fullname: Kim, Seongkoo
– sequence: 22
  givenname: Jae Wook
  surname: Lee
  fullname: Lee, Jae Wook
– sequence: 23
  givenname: Nack-Gyun
  surname: Chung
  fullname: Chung, Nack-Gyun
– sequence: 24
  givenname: Bin
  surname: Cho
  fullname: Cho, Bin
– sequence: 25
  givenname: Meerim
  surname: Park
  fullname: Park, Meerim
– sequence: 26
  givenname: Hyeon Jin
  surname: Park
  fullname: Park, Hyeon Jin
– sequence: 27
  givenname: Byung-Kiu
  surname: Park
  fullname: Park, Byung-Kiu
– sequence: 28
  givenname: Jun Ah
  surname: Lee
  fullname: Lee, Jun Ah
– sequence: 29
  givenname: Jun Eun
  surname: Park
  fullname: Park, Jun Eun
– sequence: 30
  givenname: Soon Ki
  surname: Kim
  fullname: Kim, Soon Ki
– sequence: 31
  givenname: Ji Yoon
  surname: Kim
  fullname: Kim, Ji Yoon
– sequence: 32
  givenname: Hyo Sun
  surname: Kim
  fullname: Kim, Hyo Sun
– sequence: 33
  givenname: Youngeun
  surname: Ma
  fullname: Ma, Youngeun
– sequence: 34
  givenname: Kyung Duk
  surname: Park
  fullname: Park, Kyung Duk
– sequence: 35
  givenname: Sang Kyu
  surname: Park
  fullname: Park, Sang Kyu
– sequence: 36
  givenname: Eun Sil
  surname: Park
  fullname: Park, Eun Sil
– sequence: 37
  givenname: Ye Jee
  surname: Shim
  fullname: Shim, Ye Jee
– sequence: 38
  givenname: Eun Sun
  surname: Yoo
  fullname: Yoo, Eun Sun
– sequence: 39
  givenname: Kyung Ha
  surname: Ryu
  fullname: Ryu, Kyung Ha
– sequence: 40
  givenname: Jae Won
  surname: Yoo
  fullname: Yoo, Jae Won
– sequence: 41
  givenname: Yeon Jung
  surname: Lim
  fullname: Lim, Yeon Jung
– sequence: 42
  givenname: Hoi Soo
  surname: Yoon
  fullname: Yoon, Hoi Soo
– sequence: 43
  givenname: Mee Jeong
  surname: Lee
  fullname: Lee, Mee Jeong
– sequence: 44
  givenname: Jae Min
  surname: Lee
  fullname: Lee, Jae Min
– sequence: 45
  givenname: In-Sang
  surname: Jeon
  fullname: Jeon, In-Sang
– sequence: 46
  givenname: Hye Lim
  surname: Jung
  fullname: Jung, Hye Lim
– sequence: 47
  givenname: Hee Won
  surname: Chueh
  fullname: Chueh, Hee Won
– sequence: 48
  givenname: Seunghyun
  surname: Won
  fullname: Won, Seunghyun
BackLink https://www.ncbi.nlm.nih.gov/pubmed/35952715$$D View this record in MEDLINE/PubMed
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002923332$$DAccess content in National Research Foundation of Korea (NRF)
BookMark eNptks1uEzEUhS1URNPCjjXysiAm-HdmzAIpCiWpWilVFdaW4_G0pjN2sD2V8jy8KE6mRQWxsqz7nXOudM8JOHLeGQDeYjRlmNFPOqQpQYRMUUVfgAlBiBeC8PIITDAXdUGEqI_BSYw_ECoZrfArcEy54KTCfAJ-nW9tY3rrO39rNVSugfPOOqtVB1dD0r43EfoWXpvGqhQycmNcnq2H3ocIrYOXPhj1Gc7yIAUft0Yn-2DgLFO7aA_i9Z0ZMffMZ2l6lfaxu0Pqyunxswh-2MKzy-vlavEeflVJvQYvW9VF8-bxPQXfv52v58viarW4mM-uCs2wSMWmxhXlLRJE8bqpuGKs4URVXGBUckYNbrHYaNWIhhFcYiI4a7mhuGYNrUlNT8GH0deFVt5rK72yh_fWy_sgZzfrC4kRRlVWZ_jLCG-HTW8abVwKqpPbYHsVdgfp3xNn77LRgxR1RSkj2eDs0SD4n4OJSfY2atN1yhk_REkqRHBdlYfF3j3P-hPydMYMkBHQ-QIxmFZqm1Syfh9tu7y13HdF5q7IfVdk7koWffxH9OT7X_w343fAVA
CitedBy_id crossref_primary_10_1097_RLU_0000000000005063
crossref_primary_10_12677_acm_2024_1461769
Cites_doi 10.1148/rg.2016150230
10.4143/crt.2015.290
10.1002/pbc.28257
10.4143/crt.2019.313
10.1016/j.ejca.2013.06.036
10.1002/pbc.26437
10.1111/ped.12787
10.1080/08880018.2018.1532478
10.1002/cncr.33173
10.1002/pbc.27450
10.1200/jco.2004.00.8110
10.1007/s00268-011-1410-2
10.1016/j.jpedsurg.2018.09.005
10.1002/pbc.27641
10.1002/pbc.29143
10.1016/s1470-2045(07)70276-0
10.1007/s11912-021-01016-y
10.1002/pbc.22922
10.1136/jmg.2006.041723
10.1200/jco.2015.62.1888
10.1002/pbc.28675
10.21037/tau.2020.03.27
10.1016/j.ejca.2016.09.005
10.1016/s1470-2045(07)70241-3
10.1038/s41585-018-0100-3
10.3390/cancers12030729
10.1016/j.jpurol.2020.05.168
10.1002/ijc.31946
10.1002/ijc.33147
ContentType Journal Article
Copyright Copyright © 2023 by the Korean Cancer Association 2023
Copyright_xml – notice: Copyright © 2023 by the Korean Cancer Association 2023
CorporateAuthor the Korean Pediatric Hematology and Oncology Group (KPHOG)
Korean Pediatric Hematology and Oncology Group (KPHOG)
CorporateAuthor_xml – name: the Korean Pediatric Hematology and Oncology Group (KPHOG)
– name: Korean Pediatric Hematology and Oncology Group (KPHOG)
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
ACYCR
DOI 10.4143/crt.2022.073
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
Korean Citation Index
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

CrossRef
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2005-9256
EndPage 290
ExternalDocumentID oai_kci_go_kr_ARTI_10107216
PMC9873342
35952715
10_4143_crt_2022_073
Genre Journal Article
GeographicLocations Republic of Korea
GeographicLocations_xml – name: Republic of Korea
GrantInformation_xml – fundername: the Korean Society of Pediatric Hematology-Oncology
– fundername: Korean Pediatric Hematology and Oncology Group
GroupedDBID ---
29B
5-W
53G
8JR
9ZL
AAYXX
ABDBF
ACUHS
ACYCR
ADBBV
AENEX
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
CITATION
DIK
E3Z
EBD
EF.
F5P
HYE
OK1
RPM
TR2
C1A
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
M~E
ID FETCH-LOGICAL-c419t-b81735f092a58d75a44d52a759106543e1f19bcad9d421612954f5e3184d38283
ISSN 1598-2998
2005-9256
IngestDate Sat Apr 06 03:24:31 EDT 2024
Thu Aug 21 18:38:12 EDT 2025
Fri Jul 11 09:39:03 EDT 2025
Thu Apr 03 07:09:56 EDT 2025
Tue Jul 01 03:18:51 EDT 2025
Thu Apr 24 23:10:31 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Renal tumors
Child
Epidemiology
Language English
License This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c419t-b81735f092a58d75a44d52a759106543e1f19bcad9d421612954f5e3184d38283
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Kyung-Nam Koh and Jung Woo Han contributed equally to this work.
Present address: Center for Pediatric Cancer, Department of Pediatrics, National Cancer Center, Goyang, Korea
Present address: Department of Pediatrics, Dongnam Institution of Radiological & Medical Sciences, Busan, Korea
Present address: Department of Pediatrics, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea
Present address: Department of Pediatrics, Korea University Medical Center, Seoul, Korea
ORCID 0000-0001-8936-1205
0000-0003-1009-6002
0000-0002-6376-672X
0000-0002-4837-164X
OpenAccessLink https://pubmed.ncbi.nlm.nih.gov/PMC9873342
PMID 35952715
PQID 2702187628
PQPubID 23479
PageCount 12
ParticipantIDs nrf_kci_oai_kci_go_kr_ARTI_10107216
pubmedcentral_primary_oai_pubmedcentral_nih_gov_9873342
proquest_miscellaneous_2702187628
pubmed_primary_35952715
crossref_citationtrail_10_4143_crt_2022_073
crossref_primary_10_4143_crt_2022_073
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2023-01-01
PublicationDateYYYYMMDD 2023-01-01
PublicationDate_xml – month: 01
  year: 2023
  text: 2023-01-01
  day: 01
PublicationDecade 2020
PublicationPlace Korea (South)
PublicationPlace_xml – name: Korea (South)
PublicationTitle Cancer research and treatment
PublicationTitleAlternate Cancer Res Treat
PublicationYear 2023
Publisher Korean Cancer Association
대한암학회
Publisher_xml – name: Korean Cancer Association
– name: 대한암학회
References ref13
ref12
ref14
ref30
ref11
ref10
ref2
ref1
ref17
ref16
ref19
ref18
ref24
ref23
ref26
ref25
ref20
ref22
ref21
Suh (ref15)
ref28
ref27
ref29
ref8
ref7
ref9
ref4
ref3
ref6
ref5
References_xml – ident: ref2
  doi: 10.1148/rg.2016150230
– ident: ref16
  doi: 10.4143/crt.2015.290
– ident: ref13
  doi: 10.1002/pbc.28257
– ident: ref20
  doi: 10.4143/crt.2019.313
– ident: ref19
  doi: 10.1016/j.ejca.2013.06.036
– ident: ref29
  doi: 10.1002/pbc.26437
– ident: ref11
  doi: 10.1111/ped.12787
– ident: ref23
  doi: 10.1080/08880018.2018.1532478
– ident: ref26
  doi: 10.1002/cncr.33173
– start-page: 164
  volume-title: Epidemiology and clinical outcomes of childhood Wilms tumor in Korea
  ident: ref15
– ident: ref27
  doi: 10.1002/pbc.27450
– ident: ref28
  doi: 10.1200/jco.2004.00.8110
– ident: ref25
  doi: 10.1007/s00268-011-1410-2
– ident: ref14
  doi: 10.1016/j.jpedsurg.2018.09.005
– ident: ref22
  doi: 10.1002/pbc.27641
– ident: ref5
  doi: 10.1002/pbc.29143
– ident: ref30
  doi: 10.1016/s1470-2045(07)70276-0
– ident: ref10
  doi: 10.1007/s11912-021-01016-y
– ident: ref18
  doi: 10.1002/pbc.22922
– ident: ref8
  doi: 10.1136/jmg.2006.041723
– ident: ref12
  doi: 10.1200/jco.2015.62.1888
– ident: ref4
  doi: 10.1002/pbc.28675
– ident: ref9
  doi: 10.21037/tau.2020.03.27
– ident: ref1
  doi: 10.1016/j.ejca.2016.09.005
– ident: ref17
  doi: 10.1016/s1470-2045(07)70241-3
– ident: ref21
  doi: 10.1038/s41585-018-0100-3
– ident: ref7
  doi: 10.3390/cancers12030729
– ident: ref24
  doi: 10.1016/j.jpurol.2020.05.168
– ident: ref6
  doi: 10.1002/ijc.31946
– ident: ref3
  doi: 10.1002/ijc.33147
SSID ssj0064371
Score 2.2889466
Snippet PurposeRenal tumors account for approximately 7% of all childhood cancers. These include Wilms tumor (WT), clear cell sarcoma of the kidney (CCSK), malignant...
Renal tumors account for approximately 7% of all childhood cancers. These include Wilms tumor (WT), clear cell sarcoma of the kidney (CCSK), malignant rhabdoid...
SourceID nrf
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 279
SubjectTerms Carcinoma, Renal Cell - epidemiology
Child
Humans
Kidney Neoplasms - drug therapy
Kidney Neoplasms - therapy
Male
Neoplasm Recurrence, Local
Nephroma, Mesoblastic - congenital
Nephroma, Mesoblastic - metabolism
Nephroma, Mesoblastic - pathology
Original
Republic of Korea - epidemiology
Retrospective Studies
Rhabdoid Tumor - pathology
Sarcoma
Wilms Tumor
의학일반
Title Epidemiologic and Clinical Outcomes of Pediatric Renal Tumors in Korea: A Retrospective Analysis of The Korean Pediatric Hematology and Oncology Group (KPHOG) Data
URI https://www.ncbi.nlm.nih.gov/pubmed/35952715
https://www.proquest.com/docview/2702187628
https://pubmed.ncbi.nlm.nih.gov/PMC9873342
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002923332
Volume 55
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX Cancer Research and Treatment, 2023, 55(1), , pp.279-290
journalDatabaseRights – providerCode: PRVEBS
  databaseName: EBSCOhost Academic Search Ultimate
  customDbUrl: https://search.ebscohost.com/login.aspx?authtype=ip,shib&custid=s3936755&profile=ehost&defaultdb=asn
  eissn: 2005-9256
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0064371
  issn: 1598-2998
  databaseCode: ABDBF
  dateStart: 20120301
  isFulltext: true
  titleUrlDefault: https://search.ebscohost.com/direct.asp?db=asn
  providerName: EBSCOhost
– providerCode: PRVBFR
  databaseName: Free Medical Journals
  customDbUrl:
  eissn: 2005-9256
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0064371
  issn: 1598-2998
  databaseCode: DIK
  dateStart: 20040101
  isFulltext: true
  titleUrlDefault: http://www.freemedicaljournals.com
  providerName: Flying Publisher
– providerCode: PRVERR
  databaseName: KoreaMed Open Access
  customDbUrl:
  eissn: 2005-9256
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0064371
  issn: 1598-2998
  databaseCode: 5-W
  dateStart: 20010101
  isFulltext: true
  titleUrlDefault: https://koreamed.org/journals
  providerName: Korean Association of Medical Journal Editors
– providerCode: PRVAQN
  databaseName: PubMed Central
  customDbUrl:
  eissn: 2005-9256
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0064371
  issn: 1598-2998
  databaseCode: RPM
  dateStart: 20040101
  isFulltext: true
  titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/
  providerName: National Library of Medicine
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3bbtNAEF2lqYR4QdwJNy3iIlDkEq_vvKVtQmjaBEEi8rZa30pUahfjPJTf4UP4NWa861tVpMKLk3g33ijneDw7u3OGkBe-wbwoEKZmOoOBZup6CLeUZ2m2awOnQ8_WC8Wbo5k9WZoHK2vV6fxu7Fra5P5O8PPSvJL_QRXOAa6YJfsPyFYXhRPwHvCFIyAMxythPKrLuyrZ1b0y0XG-yWFEqShbleOAPxOdz8XmFEvsrJP-NAWfUSanf4ryLC3zLltaJcikomPSuNIEtV5r_aZ5EsgPMrgFbuv042T-HmMO-zL7ramHEERZX6kMycS6art7Zf_TItwzPQdbpM3EaW0oVS5Jctz_kqb15oRUVt8-R-PV_1y3TFU8XLUcKKFxFedgRiPOUZjDQjPVY5YSzr7knLLnUva3xVtlnGXZmosPDRNcRkA6yHBrLWM7A1lbpa3NPZvz8fLwkC9Gq8Wrs-8ali3D5X1Vw2WLbDPHtlmXbA9393fHpTOAy6I4569-qMy9wCHfNgdseUVbSRZfNuG5uG-34QgtbpIbagZDh5KOt0gnSm6Ta0dqj8Yd8qvFSgrw0pKVtGQlTWNacYkWrKSSlXSd0IJs7-iQtjhJS07il4GTslvSuE7NyWLUkpO04CR9XTDyDUU-3iXL8WixN9FUKRAtMHUv13xXdwwrHnhMWG7oWMI0Q4sJxwJvF7OjIz3WPT8QoReaDCYxuHodWxjfN0PDBRf6HukmaRI9IDQQkSGYL2JXgGcGbcIdhLqIbCEi1w5Fj_RLKHigdPKxXMs3DvNlBI4DcByB4wBcj7ysep9JfZi_9HsOqPKTYM1R0B1fj1N-knGYtn7AfZaoU2j3yLMSdQ5mHtfuRBKlmx8c00Z19FzcHrkvWVCNh7n1zNGtHnFa_Kg64IjtlmT9tZCS91zHMEz28ArjPiLX69vyMenm2SZ6Ag557j9VpP8DPj_lBQ
linkProvider EBSCOhost
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Epidemiologic+and+Clinical+Outcomes+of+Pediatric+Renal+Tumors+in+Korea%3A+A+Retrospective+Analysis+of+The+Korean+Pediatric+Hematology+and+Oncology+Group+%28KPHOG%29+Data&rft.jtitle=Cancer+research+and+treatment&rft.au=Koh%2C+Kyung-Nam&rft.au=Han%2C+Jung+Woo&rft.au=Choi%2C+Hyoung+Soo&rft.au=Kang%2C+Hyoung+Jin&rft.date=2023-01-01&rft.issn=2005-9256&rft.eissn=2005-9256&rft.volume=55&rft.issue=1&rft.spage=279&rft_id=info:doi/10.4143%2Fcrt.2022.073&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1598-2998&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1598-2998&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1598-2998&client=summon